DrugPatentWatch Database Preview
Aquestive Company Profile
» See Plans and Pricing
What is the competitive landscape for AQUESTIVE, and when can generic versions of AQUESTIVE drugs launch?
AQUESTIVE has two approved drugs.
There are four US patents protecting AQUESTIVE drugs.
There are one hundred and seventy-two patent family members on AQUESTIVE drugs in twenty-two countries.
Summary for Aquestive
| International Patents: | 172 |
| US Patents: | 4 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
| PTAB Cases with Aquestive as petitioner: | See PTAB cases with Aquestive as petitioner |
Drugs and US Patents for Aquestive
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aquestive | SYMPAZAN | clobazam | FILM;ORAL | 210833-002 | Nov 1, 2018 | RX | Yes | No | 8,765,167 | Get Started for $10 | Y | Get Started for $10 | |||
| Aquestive | SYMPAZAN | clobazam | FILM;ORAL | 210833-002 | Nov 1, 2018 | RX | Yes | No | 8,603,514 | Get Started for $10 | Y | Get Started for $10 | |||
| Aquestive | SYMPAZAN | clobazam | FILM;ORAL | 210833-001 | Nov 1, 2018 | RX | Yes | No | 8,765,167 | Get Started for $10 | Y | Get Started for $10 | |||
| Aquestive | ZUPLENZ | ondansetron | FILM;ORAL | 022524-002 | Jul 2, 2010 | DISCN | Yes | No | 9,095,577 | Get Started for $10 | Y | Get Started for $10 | |||
| Aquestive | SYMPAZAN | clobazam | FILM;ORAL | 210833-003 | Nov 1, 2018 | RX | Yes | Yes | 8,765,167 | Get Started for $10 | Y | Get Started for $10 | |||
| Aquestive | SYMPAZAN | clobazam | FILM;ORAL | 210833-003 | Nov 1, 2018 | RX | Yes | Yes | 8,603,514 | Get Started for $10 | Y | Get Started for $10 | |||
| Aquestive | ZUPLENZ | ondansetron | FILM;ORAL | 022524-002 | Jul 2, 2010 | DISCN | Yes | No | 8,580,830 | Get Started for $10 | Y | Get Started for $10 | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Aquestive Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2014227693 | Get Started for $10 |
| Canada | 2664669 | Get Started for $10 |
| World Intellectual Property Organization (WIPO) | 2004066986 | Get Started for $10 |
| Australia | 2018205083 | Get Started for $10 |
| Japan | 2019048882 | Get Started for $10 |
| European Patent Office | 2968121 | Get Started for $10 |
| Japan | 2004537750 | Get Started for $10 |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
